扩大的血管周围间隙与阿尔茨海默病早期血清及神经影像学生物标志物的关联
本研究为横断面研究,纳入新加坡社区979名参与者,探讨基底节区扩大的血管周围间隙(EPVS)负荷与血液生物标志物及认知结局的关联。结果显示EPVS负荷与GFAP、NfL、p-tau181正相关,与Aβ42/40比值负相关,且在轻度认知障碍(MCI)患者中与Aβ病理关联最强。
要点
- EPVS负荷与神经炎症和淀粉样病理的血液标志物相关。
- 在MCI患者中,EPVS与Aβ病理的关联最强(OR 1.877)。
- EPVS负荷较高与视空间技能和执行功能较差相关。
核心结论
- EPVS负荷可能是CSVD和AD相关血液生物标志物病理的潜在标志物。
- 结果支持将EPVS评估纳入常规MRI以增强AD的早期检测和风险分层。
研究设计与样本
- 横断面研究,纳入新加坡社区979名参与者,平均年龄58.2±10.7岁,60.7%女性。
- 参与者接受神经心理学评估并分为认知正常、主观认知下降和MCI组。
- 量化血液生物标志物包括Aβ寡聚体、Aβ42、Aβ40、p-tau181、NfL和GFAP。
- MRI标志物(EPVS、WMH、腔隙灶和微出血)采用验证量表视觉评分。
主要发现
- EPVS负荷与GFAP(ρ=0.166,95%CI 0.104-0.228,p<0.01)、NfL(ρ=0.169,95%CI 0.112-0.242,p<0.01)和p-tau181(ρ=0.087,95%CI 0.022-0.152,p<0.01)正相关。
- EPVS负荷与Aβ42/40比值负相关(ρ=-0.077,95%CI -0.144-0.006,p<0.05)。
- 在MCI参与者中,EPVS与Aβ病理关联最强(OR 1.877,95%CI 1.045-3.370,p=0.035)。
- EPVS负荷较高与较差的视空间技能和执行功能相关(Block Design Test,OR 0.182,95%CI 0.037-0.890,p=0.035)。
临床怎么用
- 可考虑在常规MRI评估中纳入EPVS评估,以辅助AD早期检测和风险分层。
局限性
- 横断面设计无法确认EPVS的预后价值及血管功能障碍与淀粉样蛋白和tau病理之间的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Enlarged perivascular spaces (EPVS), recognized as a key feature of cerebral small vessel disease (CSVD), have emerged as a promising biomarker for vascular contribution to Alzheimer disease (AD) and other neurodegenerative diseases. Although previous studies have linked EPVS to cerebrovascular dysfunction, their relationship with AD pathology and cognitive decline remains underexplored, particularly in multiethnic cohorts. This study investigates the associations between basal ganglia EPVS burden, blood-based biomarkers (BBM), and cognitive outcomes in a Southeast Asian cohort. METHODS: This cross-sectional study drew from the Biomarkers and Cognition Study, Singapore, comprising participants recruited from the community, at Dementia Research Centre (Singapore) from 2022 to 2024. Participants underwent comprehensive neuropsychologic assessments and were classified into cognitively normal, subjective cognitive decline, and mild cognitive impairment (MCI) groups according to established diagnostic criteria. BBM including amyloid β oligomers, amyloid β42 (Aβ42) and β40 (Aβ40), phosphorylated tau 181 (p-tau181), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) were quantified. MRI Markers of CSVD (EPVS, white matter hyperintensities [WMH], lacunes, and microbleeds) were visually rated using validated scales. Associations between EPVS, biomarkers, and cognitive outcomes were analyzed using correlation or multivariable regression models adjusting for age, sex, education, cognitive diagnosis, and APOE ε4 carrier status. RESULTS: A total of 979 participants were included (mean age: 58.2 ± 10.7 years; mean education: 14.9 ± 3.5 years; 60.7% female). Elevated EPVS burden was positively correlated with higher GFAP (ρ = 0.166, 95% CI 0.104 to 0.228, p < 0.01), NfL (ρ = 0.169, 95% CI 0.112 to 0.242, p < 0.01), and p-tau181 (ρ = 0.087, 95% CI 0.022 to 0.152, p < 0.01) and inversely with the Aβ42/40 ratio (ρ = -0.077, 95% CI -0.144 to 0.006, p < 0.05)-suggesting links to neuroinflammation and amyloid pathology. Among CSVD markers, EPVS exhibited the strongest association with Aβ pathology in participants with MCI (odds ratio [OR] 1.877, 95% CI 1.045 to 3.370, p = 0.035). In addition, higher EPVS burden was linked to poorer visuospatial skills and executive function (Block Design Test, OR 0.182, 95% CI 0.037 to 0.890, p = 0.035). DISCUSSION: These findings suggest EPVS burden to be a potential marker of both CSVD and AD-related BBM pathology. The results support the potential of incorporating EPVS assessments into routine MRI evaluations to enhance early detection and risk stratification in AD. Longitudinal studies are needed to confirm the prognostic value of EPVS and to clarify mechanisms linking vascular dysfunction to amyloid and tau pathology.
引用
- Ong JJH, Leow YJ, Qiu B, et al. Association of Enlarged Perivascular Spaces With Early Serum and Neuroimaging Biomarkers of Alzheimer Disease Pathology. Neurology. 2025. PMID: 40845262. doi:10.1212/WNL.0000000000213836
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。